跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Sitadin
Approved
STANDARD
Sitadin
Sydenham Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ed1cd183017ce4c9
Company
Sydenham Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
ed1cd183017ce4c9
Drug Approval Philippines Name
Sitadin
Product Name
Sitadin
Registration Number
DRP-13837
Brand Name
Sitadin
Generic Name
Sitagliptin (as phosphate monohydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
100 mg
Manufacturer
Sydenham Laboratories, Inc.
Trader
Medchoice Endocrine Group, Inc.
Issuance Date
27 April 2023
Expiry Date
27 April 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ed1cd183017ce4c9
Type
Standard
Back to Philippines FDA Approvals
Sitadin - Philippines FDA Drug Approval Details